Skip to main content

1 July 2025

Last updated: Tuesday 1 July 2025

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

A Big Pharma deal that shares risk and reward

Friday 27 April 2012

Interviewee/Contributor

Bahija Jallal

Organisation

MedImmune

Organisations

BDO UK LLP
ERA Consulting Group
Takeda Ventures
MedNous editorial board
Allergy Therapeutics Plc
Forbion Capital Partners BV
CureVac GmbH
PharmNovo AB
Eli Lilly and Company
Celtic Pharmaceutical Holdings LP

Interviewees and Contributers

Arnaud Foussat
Stephen Megit
Andrew Briggs and Timothy Brears
Richard Zimmerman
John Burt
Jorge Santos da Silva
Catherine Pickering
Matthew Lakelin
Steven Pearson
Janet Lambert

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Shift Bioscience makes two appointments

Tuesday 20 May 2025

Steven Johnson joins Zealand Pharma

Tuesday 20 May 2025

New CSO at Zealand Pharma

Friday 9 May 2025

Henry Gosebruch to lead Galapagos spin-out

Friday 9 May 2025

New CEO at TME Pharma NV

Friday 9 May 2025

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2025 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form